Technology Roundup – Risk is limited in Facebook’s Jio stake, Intel lower after soft EPS outlook Technology
Healthcare Roundup – FDA OKs Immunomedics antibody-drug conjugate for breast cancer, Pfizer and BioNTech on go with COVID-19 vaccine study Life Science
Technology Roundup – Apple will add $75-100M in buybacks, Cleveland Research sees Q2 strength for Micron Technology
Healthcare Roundup – Liberty Health Sciences updates business amid COVID-19, Atyr Pharma on go with study of lead drug in COVID-19 Life Science
Technology Roundup – Apple wants to boost iPhone production, Amazon has path to $4,000/share Technology
Healthcare Roundup – Another U.S. study points to far higher rate of COVID infection, Money flow spikes in COVID-19 vaccine players amid rush for early data Life Science
Technology Roundup – Nokia, U.S. Cellular boosting capacity in virus-affected markets, Micron Waste to acquire Canadian COVID-19 equipment manufacturer Technology
Healthcare Roundup – U.S. COVID-19 testing capacity still constrained, Sanofi can produce up to 600M doses of COVID-19 vaccine Life Science
Technology Roundup – Facebook cancels large gatherings, Cloud customers can’t make a deal with Amazon Life Science
Healthcare Roundup – Gilead up 6% after hours on remdesivir buzz in COVID-19, New York, East Coast states extend lockdown to May 15 Life Science
Technology Roundup – California OKs now-completed Sprint/T-Mobile deal, Zoom Video enlists security heavyweights Technology
Healthcare Roundup – Baxter plans to hire up to 2K new employees, Moderna teams up with Ginkgo Bioworks Life Science
Technology Roundup – Apple unveils new budget iPhone with virtual launch, Alphabet slowing hiring for rest of year Technology
Harbour BioMed Receives Chinese Regulatory Approval of IND Application to Begin Seamless Phase 2/3 Clinical Trial of HBM9161 in Immune Thrombocytopenia Life Science
Healthcare Roundup – Teladoc services surged in Q1 due to COVID-19, Sonnet BioTherapeutics up 87% Life Science
